Header cover image

Taiwanese (TAIEX) Drug Retail Industry Analysis

UpdatedMay 24, 2026
DataAggregated Company Financials
Companies5
  • 7D1.5%
  • 3Mn/a
  • 1Y-39.9%
  • YTDn/a

Over the last 7 days, the Drug Retail industry has risen 1.5%, driven by gains from Great Tree Pharmacy of 2.0%. In the past year, the industry is down 40%. As for the next few years, earnings are expected to grow by 19% per annum.

Industry Valuation and Performance

Has the Taiwanese Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 24 May 2026NT$19.5bNT$34.3bNT$765.8m22.3x25.5x0.6x
Tue, 21 Apr 2026NT$21.5bNT$34.3bNT$687.6m20.1x31.3x0.6x
Thu, 19 Mar 2026NT$21.0bNT$34.2bNT$695.1m20.3x30.2x0.6x
Sat, 14 Feb 2026NT$23.0bNT$33.9bNT$712.6m21.6x32.2x0.7x
Mon, 12 Jan 2026NT$22.2bNT$33.9bNT$712.6m21.6x31.2x0.7x
Wed, 10 Dec 2025NT$22.0bNT$33.9bNT$712.6m20.2x30.9x0.7x
Fri, 07 Nov 2025NT$25.8bNT$33.6bNT$743.4m25.1x34.7x0.8x
Sun, 05 Oct 2025NT$27.5bNT$33.5bNT$755.9m27.7x36.4x0.8x
Tue, 02 Sep 2025NT$30.5bNT$33.5bNT$755.9m31.2x40.4x0.9x
Thu, 31 Jul 2025NT$30.9bNT$32.8bNT$754.7m27.8x40.9x0.9x
Sat, 28 Jun 2025NT$30.6bNT$32.8bNT$754.7m28x40.5x0.9x
Mon, 26 May 2025NT$32.4bNT$32.8bNT$754.7m30.9x42.9x1x
Wed, 23 Apr 2025NT$31.9bNT$32.3bNT$718.2m37.6x44.5x1x
Fri, 21 Mar 2025NT$37.9bNT$32.1bNT$701.3m45.1x54x1.2x
Sun, 16 Feb 2025NT$34.8bNT$31.8bNT$755.8m41.4x46x1.1x
Tue, 14 Jan 2025NT$32.4bNT$31.8bNT$755.8m43.3x42.9x1x
Thu, 12 Dec 2024NT$35.1bNT$31.8bNT$755.8m45.9x46.5x1.1x
Sat, 09 Nov 2024NT$38.8bNT$31.4bNT$774.1m112.6x50.1x1.2x
Mon, 07 Oct 2024NT$41.9bNT$31.0bNT$840.8m113.6x49.8x1.4x
Wed, 04 Sep 2024NT$40.8bNT$31.0bNT$840.8m112.1x48.5x1.3x
Fri, 02 Aug 2024NT$44.1bNT$30.7bNT$873.1m81.1x50.5x1.4x
Sun, 30 Jun 2024NT$44.7bNT$30.7bNT$873.1m80.2x51.2x1.5x
Tue, 28 May 2024NT$48.4bNT$30.7bNT$873.1m83.1x55.4x1.6x
Thu, 25 Apr 2024NT$48.7bNT$30.3bNT$935.7m58.5x52x1.6x
Sat, 23 Mar 2024NT$53.1bNT$30.2bNT$941.1m57x56.5x1.8x
Mon, 19 Feb 2024NT$53.0bNT$29.9bNT$964.0m60.1x55x1.8x
Wed, 17 Jan 2024NT$52.8bNT$26.8bNT$949.0m58.3x55.6x2x
Fri, 15 Dec 2023NT$52.4bNT$26.8bNT$949.0m57.5x55.2x2x
Sun, 12 Nov 2023NT$53.1bNT$26.3bNT$1.0b45.5x52x2x
Tue, 10 Oct 2023NT$57.7bNT$26.3bNT$1.0b48.1x56.5x2.2x
Thu, 07 Sep 2023NT$54.3bNT$26.3bNT$1.0b47x53.2x2.1x
Sat, 05 Aug 2023NT$52.3bNT$26.7bNT$1.3b24.7x41.5x2x
Mon, 03 Jul 2023NT$52.5bNT$26.8bNT$1.3b29.4x41.6x2x
Wed, 31 May 2023NT$49.6bNT$26.6bNT$1.3b23.3x39x1.9x
Price to Earnings Ratio

39x


Total Market Cap: NT$49.6bTotal Earnings: NT$1.3bTotal Revenue: NT$26.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Drug Retail Industry Price to Earnings3Y Average 44.9x202420252026
Current Industry PE
  • Investors are pessimistic on the Taiwanese Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 25.5x which is lower than its 3-year average PE of 44.9x.
  • The 3-year average PS ratio of 1.3x is higher than the industry's current PS ratio of 0.57x.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have declined 16% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Taiwanese Drug Retail compare with similar industries?

TW Market2.64%
Consumer Staples-2.57%
Food and Staples Retail-2.54%
Drug Retail1.54%
Big Box Super Stores0%0
Food Distributors-0.88%
Food Retail-2.88%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6469 Great Tree PharmacyNT$71.502.0%
+NT$209.6m
-48.5%PE18.9x
6844 Norbel BabyNT$66.802.8%
+NT$67.4m
-40.1%PE25.7x
7731 MARX BiotechNT$5.811.6%
+NT$47.0m
-3.5%PE70.7x

Latest News